The purpose of this study is to investigate the effects of curcumin supplement on metabolic factors and hepatic fibrosis in nonalcoholic fatty liver patients with type 2 diabetes. Subjects will participate in 3 month, two group, randomized intervention, where one group (n=25) will take 1.5g/d curcumin and the other group (n=25) will take a placebo to compare differences in outcomes between the two groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
50
NNFTRI
Tehran, Iran
Hepatic steatosis
measured by CAP score using Fibroscan
Time frame: [12 weeks]
Glucose
Time frame: [12 weeks]
HBA1C
Time frame: [12 weeks]
ALT
Time frame: [12 weeks]
AST
Time frame: [12 weeks]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.